arg-3-hyp-7-phe-bradykinin has been researched along with thromboxane b2 in 2 studies
| Studies (arg-3-hyp-7-phe-bradykinin) | Trials (arg-3-hyp-7-phe-bradykinin) | Recent Studies (post-2010) (arg-3-hyp-7-phe-bradykinin) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 52 | 2 | 3 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WM; Ahmed, A; Burch, RM; Cortes, A; Farmer, SG; Sielczak, MW | 1 |
| Burch, RM; de Garavilla, L; Kuhn, W; Steranka, LR; Togo, J; Wilson, DD | 1 |
2 other study(ies) available for arg-3-hyp-7-phe-bradykinin and thromboxane b2
| Article | Year |
|---|---|
A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep.
Topics: Airway Resistance; Allergens; Animals; Bradykinin; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Inflammation; Kallikreins; Leukocytes; Leukotrienes; Peptide Hydrolases; Prostaglandins; Respiratory Hypersensitivity; Sheep; Thromboxane B2 | 1991 |
D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock.
Topics: Analgesics; Animals; Bradykinin; Disease Models, Animal; Hemodynamics; Lipopolysaccharides; Male; Prostaglandins F; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock, Septic; Thromboxane B2 | 1989 |